Koepp MJ, Trinka E, Mah YH, Bentes C, et al. Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial. Lancet Neurol 2026;25:256-267.
PMID: 41722592